Market Cap 181.08B
Revenue (ttm) 33.42B
Net Income (ttm) 4.09B
EPS (ttm) N/A
PE Ratio 15.48
Forward PE 15.96
Profit Margin 12.24%
Debt to Equity Ratio 5.67
Volume 3,413,200
Avg Vol 2,561,164
Day's Range N/A - N/A
Shares Out 538.48M
Stochastic %K 82%
Beta 0.45
Analysts Sell
Price Target $316.69

Company Profile

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of my...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 805 447 1000
Fax: 805 447 1010
Address:
One Amgen Center Drive, Thousand Oaks, United States
PrivateProfiteer
PrivateProfiteer Nov. 14 at 2:52 AM
$AMGN is currently experiencing strong upward momentum, closing at $336.0 with an RSI of 84.68, indicating overbought conditions. The 30-day moving average (MA30) is at $302.65, and the 50-day moving average (MA50) is at $293.85, both suggesting bullish sentiment as the price is significantly above these averages. However, the high of $345.78 in the last 60 days indicates a potential resistance level, while the low of $269.77 provides a solid support base. Given the overbought RSI, a pullback may be imminent. Suggested entry is around $330.0 to capture a potential retracement. Set a stop loss at $325.0 to manage risk. Target 1 is $345.0, aligning with the 60D high, and Target 2 is $355.0, allowing for further upside if momentum continues. Monitor for signs of reversal as the RSI remains elevated. https://privateprofiteers.com
0 · Reply
SqueezedGain
SqueezedGain Nov. 14 at 12:12 AM
0 · Reply
DefenseMania
DefenseMania Nov. 13 at 5:58 PM
$ABBV $AMGN $GILD on 🔥 been accumulating these 3 for over 10 years
0 · Reply
TrustButVerifi
TrustButVerifi Nov. 13 at 5:16 PM
$VKTX BTFD! Overbloated Tech giving you a lifetime buying opportunity : VKTX is the about to disrupt Lilly's most lucrative drug in Universe! $BE $OKLO $REGN $AMGN
0 · Reply
30DeltaSpy
30DeltaSpy Nov. 13 at 4:13 PM
$GILD $AMGN bullish
0 · Reply
Albino_Trader123
Albino_Trader123 Nov. 13 at 3:06 PM
$REGN $BIIB $GILD $LLY $AMGN Nice to see green when techs are plummeting. Been hiding in these names past 2 weeks paying out
0 · Reply
clan
clan Nov. 13 at 12:45 PM
$MNKD $26 in '26 $MRK $JNJ $AMGN all may want a piece of MannKind.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 12:58 AM
$AMGN is currently trading at $335.97, near its 60D high of $336.78, indicating strong recent performance. The RSI at 81.7 suggests that the stock is overbought, which may lead to a price correction. The MA30 at $300.02 and MA50 at $291.64 indicate a bullish trend; however, the high RSI raises caution. Directional bias is mixed: while the stock is in a strong uptrend, the overbought RSI signals potential weakness. Suggested entry is at $335.00, slightly below the last close to capture momentum. Set a stop loss at $327.85, just below the recent support level indicated by the ATR of $8.12. Targets are set at $340.00 (near the 60D high) and $345.00, allowing for potential upside while managing risk. Monitor for signs of reversal given the high RSI. https://privateprofiteers.com
0 · Reply
albiegf13
albiegf13 Nov. 12 at 8:53 PM
0 · Reply
susberk
susberk Nov. 12 at 6:08 PM
$AMGN am i wrong or does this seem very overbought? doesnt this always happen after earnings?
0 · Reply
Latest News on AMGN
Trade Tracker: Bill Baruch buys more Amgen

Nov 13, 2025, 1:54 PM EST - 17 hours ago

Trade Tracker: Bill Baruch buys more Amgen


Cramer's Stop Trading: Amgen

Nov 13, 2025, 10:30 AM EST - 20 hours ago

Cramer's Stop Trading: Amgen


Amgen CEO talks trial results of cardiac drug Repatha

Nov 10, 2025, 7:40 PM EST - 3 days ago

Amgen CEO talks trial results of cardiac drug Repatha


Amgen: Buy This Cheap Biotech Leader

Nov 8, 2025, 12:11 AM EST - 6 days ago

Amgen: Buy This Cheap Biotech Leader


Stock Of The Day: Will Amgen Reverse Again?

Nov 6, 2025, 10:41 AM EST - 7 days ago

Stock Of The Day: Will Amgen Reverse Again?


Amgen: Q3 Earnings Indicate Strong Emphasis On R&D

Nov 5, 2025, 12:40 PM EST - 8 days ago

Amgen: Q3 Earnings Indicate Strong Emphasis On R&D


Amgen Inc. (AMGN) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 7:36 PM EST - 9 days ago

Amgen Inc. (AMGN) Q3 2025 Earnings Call Transcript


AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

Nov 4, 2025, 4:01 PM EST - 9 days ago

AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS


AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND

Oct 31, 2025, 4:01 PM EDT - 13 days ago

AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND


AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS

Oct 29, 2025, 4:01 PM EDT - 15 days ago

AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS


Cramer's Stop Trading - Amgen

Oct 3, 2025, 10:22 AM EDT - 5 weeks ago

Cramer's Stop Trading - Amgen


Amgen Shares Cross Above 200 DMA

Oct 1, 2025, 11:35 AM EDT - 6 weeks ago

Amgen Shares Cross Above 200 DMA


Amgen: Imdelltra Could Be The Next Game Changer

Sep 24, 2025, 10:17 AM EDT - 7 weeks ago

Amgen: Imdelltra Could Be The Next Game Changer


Amgen: Buy The Dip Opportunity

Sep 14, 2025, 8:30 AM EDT - 2 months ago

Amgen: Buy The Dip Opportunity


AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE

Aug 29, 2025, 4:01 PM EDT - 2 months ago

AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE


PrivateProfiteer
PrivateProfiteer Nov. 14 at 2:52 AM
$AMGN is currently experiencing strong upward momentum, closing at $336.0 with an RSI of 84.68, indicating overbought conditions. The 30-day moving average (MA30) is at $302.65, and the 50-day moving average (MA50) is at $293.85, both suggesting bullish sentiment as the price is significantly above these averages. However, the high of $345.78 in the last 60 days indicates a potential resistance level, while the low of $269.77 provides a solid support base. Given the overbought RSI, a pullback may be imminent. Suggested entry is around $330.0 to capture a potential retracement. Set a stop loss at $325.0 to manage risk. Target 1 is $345.0, aligning with the 60D high, and Target 2 is $355.0, allowing for further upside if momentum continues. Monitor for signs of reversal as the RSI remains elevated. https://privateprofiteers.com
0 · Reply
SqueezedGain
SqueezedGain Nov. 14 at 12:12 AM
0 · Reply
DefenseMania
DefenseMania Nov. 13 at 5:58 PM
$ABBV $AMGN $GILD on 🔥 been accumulating these 3 for over 10 years
0 · Reply
TrustButVerifi
TrustButVerifi Nov. 13 at 5:16 PM
$VKTX BTFD! Overbloated Tech giving you a lifetime buying opportunity : VKTX is the about to disrupt Lilly's most lucrative drug in Universe! $BE $OKLO $REGN $AMGN
0 · Reply
30DeltaSpy
30DeltaSpy Nov. 13 at 4:13 PM
$GILD $AMGN bullish
0 · Reply
Albino_Trader123
Albino_Trader123 Nov. 13 at 3:06 PM
$REGN $BIIB $GILD $LLY $AMGN Nice to see green when techs are plummeting. Been hiding in these names past 2 weeks paying out
0 · Reply
clan
clan Nov. 13 at 12:45 PM
$MNKD $26 in '26 $MRK $JNJ $AMGN all may want a piece of MannKind.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 12:58 AM
$AMGN is currently trading at $335.97, near its 60D high of $336.78, indicating strong recent performance. The RSI at 81.7 suggests that the stock is overbought, which may lead to a price correction. The MA30 at $300.02 and MA50 at $291.64 indicate a bullish trend; however, the high RSI raises caution. Directional bias is mixed: while the stock is in a strong uptrend, the overbought RSI signals potential weakness. Suggested entry is at $335.00, slightly below the last close to capture momentum. Set a stop loss at $327.85, just below the recent support level indicated by the ATR of $8.12. Targets are set at $340.00 (near the 60D high) and $345.00, allowing for potential upside while managing risk. Monitor for signs of reversal given the high RSI. https://privateprofiteers.com
0 · Reply
albiegf13
albiegf13 Nov. 12 at 8:53 PM
0 · Reply
susberk
susberk Nov. 12 at 6:08 PM
$AMGN am i wrong or does this seem very overbought? doesnt this always happen after earnings?
0 · Reply
Albino_Trader123
Albino_Trader123 Nov. 12 at 4:22 PM
$REGN $BIIB $GILD $AMGN safe place to hide for now until tech finds stabilizes...
0 · Reply
Vernskii
Vernskii Nov. 12 at 3:04 PM
0 · Reply
JFDI
JFDI Nov. 12 at 3:01 PM
$AMGN boom
0 · Reply
Quantumup
Quantumup Nov. 12 at 11:41 AM
Citizens reiterated $ESPR Market Outperform-$4, and said, KOLs Support Use of Bempedoic Acid in Statin-Intolerant Patients and Underscore the Need for LDL-Lowering Therapies in High-CV-Risk Patients. $PFE $AMGN $SNY $REGN NVS AZN MRK NAMS Citizens JMP additionally said: Yesterday afternoon, Esperion hosted a KOL event highlighting the ongoing success of the bempedoic acid franchise and emphasized the importance of bempedoic acid availability for statin-intolerant patients. The bempedoic acid franchise demonstrated robust growth in 3Q25 due to increased demand supported by investment in payer access and digital campaigns. Importantly, both KOLs, in our view, were highly supportive of the use of bempedoic acid for LDL lowering in statin-intolerant patients and in the increasing statin-refusal patient population.
1 · Reply
moneybag888
moneybag888 Nov. 12 at 9:06 AM
$AMGN 🤔
0 · Reply
Juba2022
Juba2022 Nov. 12 at 2:38 AM
$AMGN Exit liquidity rally!!! CEO/Cramer staged with timely Cholesterol statement...real or not Market will correct once the effect fades, or some counter hype statement.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 12:34 AM
$AMGN is currently trading at $335.97, near its 60D high of $336.78, indicating strong recent performance. The RSI at 81.7 suggests that the stock is overbought, which may lead to a price correction. The MA30 at $300.02 and MA50 at $291.64 indicate a bullish trend; however, the high RSI raises caution. Directional bias is mixed: while the stock is in a strong uptrend, the overbought RSI signals potential weakness. Suggested entry is at $335.00, slightly below the last close to capture momentum. Set a stop loss at $327.85, just below the recent support level indicated by the ATR of $8.12. Targets are set at $340.00 (near the 60D high) and $345.00, allowing for potential upside while managing risk. Monitor for signs of reversal given the high RSI. https://privateprofiteers.com
0 · Reply
mikesterz7
mikesterz7 Nov. 11 at 10:57 PM
$AMGN CEO Bob Bradway told CNBC’s Jim Cramer that nearly all heart attacks stem from “modifiable” risks like high LDL, emphasizing the need for early cholesterol control.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 11 at 10:25 PM
0 · Reply
topstockalerts
topstockalerts Nov. 11 at 9:46 PM
The Dow Jones Industrial Average rallied to a fresh closing record Tuesday, while the Nasdaq Composite struggled as investors moved money away from technology stocks into other parts of the market that traded at lower valuations. The 30-stock Dow rose 559.33 points, or 1.18%, to close at 47,927.96, with those on Wall Street buying up shares of various blue-chip names, including health care giants Merck Amgen and Johnson & Johnson. The S&P 500 also rose 0.21% to finish at 6,846.61. However, the tech-heavy Nasdaq lost 0.25% to settle at 23,468.30. Artificial intelligence cloud infrastructure provider CoreWeave was among the laggards of the session. Shares slid more than 16% after the company’s guidance disappointed investors, hurting the AI trade. Along with that, shares of AI chip darling Nvidia pulled back about 3% after SoftBank sold its entire stake in the chipmaker for more than $5 billion. $MRK $JNJ $AMGN $SPY
0 · Reply
CH14N
CH14N Nov. 11 at 9:30 PM
$AMGN to da moon
0 · Reply
MarcoFla99
MarcoFla99 Nov. 11 at 7:53 PM
$AMGN Beast mode! Love this holding!!
0 · Reply